Type 1 Diabetes and Multiple Sclerosis

Abstract
Type 1 diabetes mellitus (T1D) and multiple sclerosis (MS) are organ-specific autoimmune diseases that differ in clinical manifestations and pathogenesis. The chronic hyperglycemia characteristic of T1D results from destruction of the pancreatic insulin-producing β-cells, whereas the neurologic disabilities associated with MS result from myelin sheath degeneration in the central nervous system.1-3